NCT03264625View on ClinicalTrials.gov

The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2017

Primary Completion Date

May 28, 2021

Study Completion Date

July 30, 2021

Conditions
Peritoneal Dialysis-associated PeritonitisVitamin D Deficiency
Interventions
DRUG

Cholecalciferol (2000iu qd)

Patients will receive oral Cholecalciferol (2000IU qd) apart from routine therapy for PD

OTHER

Routine therapy for PD

Patients randomized to the placebo group will receive routine therapy for PD.

Trial Locations (1)

Unknown

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT03264625 - The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis | Biotech Hunter | Biotech Hunter